Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |